Harrow Health
HROW
$16.76
Share price
3.71%
Change (1 day)
-22.44%
Change (1 year)
Categories
Harrow Health (HROW) - P/B ratio
P/B ratio as of May 2024 : 8.12
According to Harrow Health's latest financial reports the company has a price-to-book ratio of 8.12.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Harrow Health - P/B ratio (from 2008 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 5.59 | -65.39% |
| 2022-12-31 | 16.1 | -24.09% |
| 2021-12-31 | 21.3 | 222.95% |
| 2020-12-31 | 6.58 | -9.1% |
| 2019-12-31 | 7.24 | 29.45% |
| 2018-12-31 | 5.60 | -58.09% |
| 2017-12-31 | 13.4 | 159.15% |
| 2016-12-31 | 5.15 | -110.55% |
| 2015-12-31 | -48.8 | -672.94% |
| 2014-12-31 | 8.52 | 327.14% |
| 2013-12-31 | 1.99 | -69.8% |
| 2012-12-31 | 6.61 | -688.48% |
| 2011-12-31 | -1.12 | -90.74% |
| 2010-12-31 | -12.1 | -129.8% |
| 2009-12-31 | 40.7 | 1096.25% |
| 2008-12-31 | 3.40 | |
| 2007-12-31 | N/A | |
| 2006-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 0.6522 | -91.97% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 1.96 | -75.88% | 🇺🇸 USA |